Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor.

Managed care (Langhorne, Pa.)

Volumn 12, Issue 7, 2003, Pages 39-46

  Lam, Fung ^a   Istwan, Niki B ^a   Jacques, Debbie ^a   Coleman, Suzanne K ^a   Stanziano, Gary J ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; METHODOLOGY; NEWBORN; ORAL DRUG ADMINISTRATION; PERINATAL CARE; PREGNANCY; PREMATURE LABOR; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, ORAL; ADULT; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT, NEWBORN; INJECTIONS, SUBCUTANEOUS; OBSTETRIC LABOR, PREMATURE; PERINATAL CARE; PREGNANCY; RECURRENCE; RETROSPECTIVE STUDIES; TERBUTALINE; TOCOLYTIC AGENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 0041976856     PISSN: 10623388     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)